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Abstract.  Cultured human lung fibroblasts produce a 
large,  nonhydrophobic heparan  sulfate proteoglycan 
that accumulates in the extracellular matrix of the 
monolayer (Heremans, A., J. J.  Cassiman,  H. Van den 
Berghe, and G.  David.  1988. J.  Biol.  Chem.  263: 
4731-4739).  A panel of four monoclonal antibodies, 
specific for four distinct epitopes on the 400-kD core 
protein of this extracellular matrix heparan sulfate pro- 
teoglycan, detects similar proteoglycans in human epi- 
thelial cell cultures.  Immunohistochemistry of human 
tissues with the monoclonal antibodies reveals that 
these proteoglycans are concentrated at cell-matrix  in- 
terfaces. Immunogold labeling of ultracryosections of 
human skin indicates that the proteoglycan epitopes 
are nonhomogeneously distributed over the width of 
the basement membrane.  Immunochemical investiga- 
tions and amino acid sequence analysis indicate that 
the proteoglycan from the fibroblast matrix shares sev- 
eral structural  features with the large,  low density 
heparan  sulfate proteoglycan isolated from the Engel- 
breth-Holm-Swarm sarcoma.  Thus,  both epithelial cell 
sheets and individual mesenchymal cells accumulate a 
large heparan  sulfate proteoglycan(s) at the interface 
with the interstitial  matrix,  where the proteoglycan 
may adopt a  specific topological orientation with re- 
spect to this matrix. 
H 
EPARAN sulfate  proteoglycans  (HSPGs) t occur as 
integral components of basement membranes in prob- 
ably all mammalian  tissues and in basement mem- 
brane-producing tumors (Anderson and Fambrough,  1983; 
Edge and Spiro,  1987; Hassell et al.,  1980; Heathcote and 
Orkin,  1984; Kanwar et al., 1984; Kato et al., 1988; Oohira 
et al.,  1982; Robinson and Gospodarowicz, 1984; Tyree et 
al.,  1984).  Their functions have not yet been well estab- 
lished,  but the HSPGs are known  to interact  with several 
other  basement  membrane  constituents  (Fujiwara  et  al., 
1984; Gallagher et al.,  1986; Paulsson et al.,  1986). These 
interactions  probably contribute to the general  architecture 
of the basement membrane and may play a role in tissue mor- 
phogenesis and growth control (David and Bernfield,  1982). 
Basement membrane HSPGs may also influence the specific 
properties of certain  matrices since they determine the per- 
meability of the glomerular basement membrane (Kanwar et 
al.,  1980)  and  have been implicated  in  the anchorage  of 
asymmetric acetylcholinesterase to the extracellular  matrix 
1.  Abbreviations  used in  this paper:  ECM,  extracellular matrix;  EHS, 
Engelbreth-Holm-Swarm;  HSPG,  heparan sulfate  proteoglycan;  LDPG, 
low density heparan sulfate proteoglycan. 
(ECM) of the neuromuscular junction (Anderson and Fam- 
brough,  1983; Brandan et al.,  1985). Finally, by activating 
protease inhibitors,  HSPGs may also modulate serine pro- 
tease  activity as documented for the Reichert's  membrane 
(Pejler et al., 1987) and for the HSPGs of mouse mammary 
epithelial  cells (Pejler and David,  1987). Perhaps the latter 
property of the HSPGs contributes to the metabolic stability 
of the basement membranes. 
Immunohistochemical  and  cytochemical  data  have  sug- 
gested that the basement membrane HSPGs occur specifical- 
ly in basement membranes (Couchman, 1987; Hassell et al., 
1980). Basement membrane HSPGs from different sources 
appear antigenically  related  to each other  (Wewer et al., 
1985) but are unrelated to the cell-associated  HSPGs (Dzia- 
dek et al.,  1985; Jalkanen  et al.,  1988; Keller and Furth- 
mayr, 1986; Stow and Farquhar,  1987). Yet, despite antigenic 
cross-reactivity,  structural  variations  have been described 
for HSPGs isolated  from different  basement membranes. 
Most tissues and basement membrane-producing cells syn- 
thesize a large,  low density HSPG (LDPG) with a 400-kD 
core protein (Anderson and Fambrough, 1983; Fenger et al., 
1984; Hassell et al.,  1985; Tyree et al.,  1984), but small, 
high density HSPGs have also been reported (Edge and Spiro, 
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al., 1985; Kato et al., 1987; Tyree et al., 1984). These occur 
together with the large proteoglycan or, as described for the 
glomerular basement membrane (Kanwar et al.,  1984),  as 
the predominant HSPGs. The basis for these structural varia- 
tions is still a matter of discussion, but there is a possibility 
that basement membranes may contain a family of proteogly- 
cans (Couchman,  1987).  Some investigations suggest that 
the different forms represent precursor-product relationships 
(Hassell et al.,  1985;  Klein et al.,  1988). 
HSPGs are also found in the ECM of several cultured epi- 
thelial and mesenchymal cells (David and Bernfield, 1981; 
Eldridge et al.,  1986;  Hedman et al.,  1979;  Johansson et 
al.,  1985;  Nevo et al.,  1984;  Norling et al.,  1981; Oohira 
et al., 1983; Robinson and Gospodarowicz, 1984; Singer et 
al., 1987; Wewer et al., 1985; Woods et al., 1985). In previ- 
ously reported investigations, we have isolated and identified 
the major HSPG from the ECM of cultured human lung 
fibroblasts.  In the present work, we provide evidence that 
this matrix HSPG is related to the large HSPGs that occur 
in basement membranes and we propose that, in basement 
membranes, the HSPGs might be vectorially inserted in the 
matrix. 
Materials and Methods 
Materials 
Unless stated otherwise in the text, the origin of the chemicals, enzymes, 
and culture media was as indicated in previous reports (Heremans et al., 
1988;  Lories et al.,  1989). 
Cultures of amnintic epithelial cells, fetal human lung fibroblasts, and 
normal adult human skin fibroblasts were established in our laboratory 
(Lories et al.,  1986).  Human mammary epithelial cells (HBL 100) were 
provided by the EG&G Mason Research Institute (Worcester, MA) through 
the courtesy  of Dr.  Jensen.  These  cultures  were  grown  in  Duibecco's 
modified Eagle's minimal essential medium containing 10% (vol/vol) FCS. 
Human epidermal keratinocytes were obtained from Clonetics Corporation 
(San Diego, CA) as a kit (Epipack tm) containing secondary cell cultures 
and all media and solutions required for subculturing. All cells were grown 
in plastic falcon flasks. 
Antibodies 
Four  mAbs  (F64-3H8,  F65-4B1,  F65-7H9,  and  F65-9C9)  were  raised 
against HSPG purified from the ECM of cultured human lung fibroblasts 
(anti-ECM HSPG mAbs) and were shown to recognize four different epi- 
topes on the core protein of this matrix HSPG (Heremans et al.,  1988). 
These four mAbs do not cross react with cell surface HSPGs isolated from 
the same cultures (Heremans et al., 1988). mAb F58-7Fg, which reacts with 
the 48- and 90-kD core proteins of these cell surface-associated HSPGs, 
was raised and characterized as described previously (Lories et al., 1989). 
Rabbit antisera were raised against the LDPG from the murine Engelbreth- 
Holm-Swarm (EHS) sarcoma (anti-EHS LDPG antiserum) and character- 
ized as described before (Pauisson et al.,  1987).  Rabbit anti-human type 
IV collagen was kindly provided by Dr.  Charles Lapi~re (University of 
Liege, Liege, Belgium). 
Processing of Culture Media, Cell  Layers, and ECMs 
of Cultured Cells 
Culture media of confluent monolayers were decanted. The cell layers were 
briefly rinsed with PBS before three extractions with 10 ml Triton X-100 
buffer (0.5% [vol/vol]  Triton X-100, 10 mM Tris-Ci, 50 mM 6-aminohex- 
anoic acid, 10 mM EDTA, 5 mM N-ethylmaleimide, 5 mM benzamidine, 
1 mM PMSF, 3/zM pepstatin A, pH 8) for 10 min at 4°C. The media and 
the detergent extracts of the cell layers were cleared by centrifugation and 
concentrated as described before (Lories et al., 1987). The ECM remaining 
on the dish after detergent extraction was scraped in 10 ml PBS and pooled 
with the pellet of the cell extract. The combined pellets were resuspended 
in 1 ml PBS containing 50 mM 6-aminohexanoic acid, 5 mM benzamidine, 
5 mM N-ethylmaleimide, 1 mM PMSF, and 3 /~M pepstatin A. 
Enzyme Treatments, Electrophoresis, and 
Western Blotting 
Samples of resuspended matrix, media, or cell extracts were incubated for 
4 h at 37°C either with or without 1 mlU of heparitinase in 100 mM NaCl, 
1 mM CaCI2,  50 mM Hepes, pH 7, in the presence of protease inhibitors 
(50 mM 6-aminohexanoic acid, 5 mM benzamidine, 3/~M pepstatin A, 5 
mM N-ethylmaleimide, 1/zg/ml leupeptin, 1 mM PMSF) and 100 ~g/ml 
BSA. The enzyme-treated and the untreated matrix fractions were pelleted 
by centrifugation at 10,000 g for 10 min at 4°C, resuspended in 10 mM Tris- 
CI,  1 mM EDTA, 2% SDS, pH 6.8, and boiled for 3 rain. Electrophoresis 
was performed in SDS-agarose slab gels (4% NuSieve agarose; FMC Bio- 
products, Rockland, ME) in 90 mM "Iris, 90 mM borate, 2 mM EDTA, 
0.1% SDS pH 8) for 3 h at 50 V as described before (Heremans et al., 1988). 
Electrotransfer onto Z probe (Bio-Rad Laboratories, Richmond, CA) was 
done at 30 V  for 16 h at 4°C in 25  mM Tris,  192 mM glycine, 0.01% 
NAN3, 20% methanol (Towbin et al.,  1979).  For the peptide mapping ex- 
periment, the heparitinase-digested matrix extracts were resuspended in 50 
mM Tris-Cl, pH 8, and digested with 50/~g/ml Staphylococcus  aureus  V8 
protease for 30 rain at room temperature. The samples were subjected to 
SDS-PAGE in a 6-26% separating gel (Laemmli, 1970) and electrotrans- 
ferred onto Z probe. 
After transfer and inactivation in 0.5% (wt/vol) casein, 600 mM NaCI 
in 10 mM phosphate buffer, pH 7.4, for 1 h at 37°C, the Z probe membranes 
were incubated for I h at room temperature with a mixture of the anti-ECM 
HSPG mAbs (20/~g/ml of each) or with anti-EHS LDPG polyclonal antise- 
rum (diluted 1:1,000) in PBS containing 0.5% casein. The membranes were 
rinsed, incubated with the appropriate peroxidase-conjugated second anti- 
bodies (DAKOPATTS, Glostrup, Denmark), and stained as described before 
(Heremans et al.,  1988). 
ImmunoajOinity Chromatography and 
Immunoprecipitation Assays 
2 mg of each anti-ECM HSPG mAb were coupled to 1 ml CNBr-activated 
Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden) as described 
previously (Heremans et al., 1988).  Matrix proteoglycan was radiolabeled 
using  Nat:SI  and  chloramine T  as described before (Heremans et ai., 
1988).  Mixtures of 20/~g of each of the immobilized mAbs were incubated 
with heparitinase-digested t25I-labeled  fibroblast matrix HSPG in 10 mM 
Tris-CI, pH 7.6, containing 0.15 M NaCI and 0.5% (wt/vol) casein. After 
overnight incubation at 4°C, the bound materials were eluted in 4 M guano- 
dine hydrochloride, 0.5 % (vol/vol) Triton XA00, precipitated with 3 vol eth- 
anol, and resuspended in 50 mM Tris-Cl, pH 7.6, 150 mM NaCI, 0.1% 
(vol/vol) SDS, 1% (vol/vol) Triton X-100, and 1% (vol/vol) sodium deoxy- 
cholate (assay buffer). To assess the cross-reactivity of this immunopurified 
proteoglycan, 12 nag protein A-Sepharose beads (a quantity sufficient to 
bind  1 mg of IgG)  were saturated with  100/~1  rabbit anti-mouse IgGs 
(DAKOPATTS) or with 50/zl of rabbit antiserum raised against the LDPG 
of the murine EHS sarcoma (anti-EHS LDPG) during an overnight incuba- 
tion at 4°C in assay buffer.  After binding, the protein A-rabbit anti-mouse 
IgG and the protein A-rabbit anti-EHS LDPG beads were washed with as- 
say buffer and incubated overnight at 4°C with similar amounts of immune- 
purified lesI-labeled fibroblast matrix HSPG in assay buffer containing 20 
#g/ml heparin, 20 t~g/ml chondroitin sulfate, and 50 #g/ml casein. At the 
end of the incubation, the beads were pelleted and rinsed with assay buffer. 
The amount of 125I radioactivity was assessed in the supernatant, rinses, 
and pellets. 
Immunoperoxidase Reaction on Cells and 7Issues  for 
Light Microscopy 
Cultured cells were analyzed as described before (David et al., 1989).  Hu- 
man tissue samples were frozen in isopentane that was precooled in liquid 
nitrogen. After preincubation in PBS containing 1% casein (15 rain), cell 
cultures and 6-/~m cryosections of tissues were reacted, successively, with 
the first antibody preparation (1  h),  with peroxidase-linked rabbit anti- 
mouse or swine anti-rabbit IgG second antibodies (DAKOPATTS) diluted 
1:50 in PBS-casein (1 h), and with 0.05%  3.3'-diaminobenzidine and 0.01% 
HeO2 in 50 mM Tris-CI, pH 7.6 (10 rain at room temperature). The reac- 
tion was enhanced with 1% osmium-tetroxide in 0.1  M phosphate buffer, 
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mixed with purified HSPG from the matrix of cultured fibroblasts for 1 h 
at room temperature before incubation with the tissue. 
lmmunogold Labeling  for Electron Microscopy 
20-#m cryosections of tissue were fixed with 2 % acrolein (Polysciences, 
Inc., Warrington, PA) in 0.1 M phosphate buffer, pH 7.4, for 15 min on ice. 
The cytochemical reaction procedure was analogous to that used in light mi- 
croscopy. After the immunohistochemical reaction and a  supplementary 
fixation in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer,  pH 7.4, 
the cells or tissues were dehydrated, embedded in epon, and sectioned with 
an ultramicrotome (Ultratome 2128  IV; LKB Instruments, Inc., Bromma, 
Sweden). Alternatively, to avoid possible antibody penetration problems, 
the immunogold labeling was performed on ultracryosections. For that pur- 
pose, mouse and human skin and human umbilical cord were fixed in 2% 
paraformaldehyde in 0.1  M  phosphate buffer for 20 min at 4°C and then 
treated with 0.1 M glycine in PBS. Freezing, sectioning, and treatment of 
the ultracryosections were essentially as described by others (Geuze et al., 
1981; Tokuyasu  and Singer,  1976).  The primary antibody solutions con- 
tained 0.1% Tween 20 and 0.1% Triton X-100. The anti-ECM HSPG mAbs 
were used at a concentration of 0.1 mg/ml. The dilution of the anti-EHS 
LDPG and of the anti-type IV collagen antibodies was  1:200 and  1:100, 
respectively. The auroprobes (GAM-G5 and GAR-G5; Janssen Pharmaceu- 
tica, Beerse, Belgium) were diluted 1:10 in PBS containing 1% gelatin, 0.1% 
Tween, and 0.1% Triton X-100 and were applied for 1 h at room tempera- 
ture. In some experiments, the detergents were omitted from the buffer solu- 
tion. Fixation was a critical step. Other tested fixatives or longer fixation 
times sometimes led to better tissue preservation but markedly reduced the 
intensity of the labeling obtained with the mAbs. 
Amino Acid Sequence Analysis 
Fibroblast matrix HSPG was purified by cesium chloride density ultracen- 
trifugation, ion exchange chromatography on mono Q, and gel filtration on 
Sepharose CL4B as described previously (Heremans et al., 1988).  Purified 
matrix HSPG was reduced with 10 mM DTT in 4 M guanodine hydrochlo- 
ride, 50 mM Tris-CI, 50 mM octylglucoside, pH 8, for 4 h at room tem- 
perature, and alkylated with 40 mM iodoacetamide overnight at room tem- 
perature.  The sample was then precipitated with 3  vol of 95 % ethanol, 
resuspended in 0.1% SDS, 44 mM N-tris(hydroxymethyl)methyl-2-amino- 
ethane sulfonic acid,  166 ram bis Tris, pH 7.35,  and incubated for 1 h at 
37°C with 0.25 #g of S.  aureua V8 protease. After digestion, the sample 
was boiled in 2% SDS and subjected to SDS-PAGE (gradient 6-26% total 
acrylamide and 2.5% cross-linker) using the Jovin system 3328.IV (Moos 
et al., 1988).  The fractionated digest was electrotransferred to a polyvinyli- 
dene difluoride sheet (Immobilon TM;  Millipore Continental Water Sys- 
tems, Bedford, MA) in a phosphate buffer (10 mM NaH2PO4,  20%  [vol/ 
vol] methanol, pH 6.8) for 6 h at 0.5 A. After electrotransfer, the membrane 
was stained for 10 min at room temperature with 1% (wt/vol) Coomassie 
brilliant blue R-250 in 50% (vol/vol) methanol and destained in 10% glacial 
acetic acid, 50%  (vol/vol) methanol. One major protein band at  13.5 kD 
was excised, cut into small pieces (2  x  4  nun), and placed on top of a 
polyhrene-conditioned glass fiber filter in the cartridge block of a protein 
sequencer (477A; Applied Biosystems, Inc., Foster City, CA). Phenylthio- 
hydantoin derivatives of amino acids produced by the sequencer were iden- 
tiffed on-line using an analyzer (120A;  Applied Biosystems, Inc.). 
Results 
lmmunodetection of  Matrix HSPG in 
Cultured Cell Lines 
The panel of four mAbs reacting with four distinct epitopes 
in the core protein of the major matrix HSPG of lung fibro- 
blasts was used to analyze other cultured human cell lines: 
i.e., mammary epithelial cells, keratinocytes, and amnion 
cells. When Western blots of the matrix fractions of the cell 
layers were reacted with a mixture of the anti-ECM HSPG 
mAbs, one single heparitinase-sensitive protein was detected 
in each cell lined examined (Fig.  1 a).  Staining with each 
mAb separately' yielded similar results, indicating that all 
four core epitopes were expressed by all cells tested (not 
shown). The fibroblast core protein comigrated with the A 
chain of laminin (not shown), suggesting an apparent relative 
molecular mass of,,o400,000. The fibroblast core protein and 
all other cross reacting heparitinase-resistant c0reshad simi- 
lar sizes.  This similarity of the sizes of the heparitinase-di- 
gested cores contrasted with the variation of the apparent rel- 
ative molecular masses of the intact HSPGs in the different 
monolayers (Fig.  1 a). This suggests tissue variation in the 
length or the number of the glycosaminoglycan  chains. The 
detergent extracts of the cells contained little cross-reactive 
material (not shown). Variable  amounts of immunoreactive 
proteoglycan were secreted in the culture media of all ana- 
lyzed cell types (Fig. 1 b). After heparitinase digestion, the 
culture media contained some immunoreactive 400-kD core 
protein  but  also  smaller proteins  that carried  the  matrix 
HSPG epitopes. Interestingly, these proteins were of rather 
similar mobility within the different cell lines.  A  further 
confirmation  of the similarity of  the HSPGs that were detected 
in the matrix of epithelial cells (mammary gland cells and 
amniotic epithelial cells) and mesenchymal cells (lung fibro- 
blasts)  was achieved by V8 protease digestion of heparit- 
inase-treated matrix preparations.  After SDS-PAGE and elec- 
trotransfer of  the digests, staining with the mixture of  the four 
mAbs yielded very similar patterns of immunoreactive V8 
peptides in the different cell lines (Fig. 2). Similar peptide 
patterns in different cell types were also obtained when mAbs 
were used individually (not shown). Thus, several  cultured 
epithelial cells seem to express the fibroblast matrix HSPG. 
Moreover, the epitopes defined by the mAb panel appear 
unique and specific for this type of proteoglycan since only 
heparitinase-sensitive molecules were detected. 
Immunocytochemistry of human epithelial (Fig. 3 a) and 
fibroblast (Fig. 3 b) monolayers using theanti-ECM HSPG 
mAb panel assigned the epitopes to the reticular network of 
fibrillar material surrounding the cultured cells.  In fibro- 
blasts, this matrix staining pattern was clearly distinct from 
the cell surface staining obtained with an antibody directed 
against an integral membrane HSPG (Fig. 3 c). There was 
no difference in staining pattern among the four anti-ECM 
HSPG mAbs available, and no additional staining was ob- 
tained after permeabilization of the cells with aceton (data 
not shown). Heparitinase digestion of the cultures before the 
incubation with the antibodies did not affect the staining in- 
tensity or pattern (not shown). Control experiments in which 
the mAbs were omitted were negative (not shown). 
Immunolocalization of  Matrix HSPG 
in Human 7Issues 
To locate the matrix HSPG in vivo, several human tissues 
were screened with the anti-ECM HSPG mAbs. In light ~_i- 
croscopy, the most prominent reaction of the mAbs occurred 
at the level of the basement membranes (Fig. 4). In human 
skin sections (Fig. 4 a), the dermo-epidermal junction and 
the basement membranes limiting the epidermal adnexae 
(hair follicles, sebaceous glands,  and sweat glands) were 
heavily stained. The keratinocytes were negative. In the un- 
derlying dermis and at the light microscopical level, staining 
around individual fibroblasts was not a prominent feature. 
Blood vessels and smooth muscle cells, however, were sur- 
rounded by a strongly reactive belt. Intense staining of the 
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sions of scraped ECM material (a) and concentrated culture media 
(b) of keratinocytes (lanes I  and 2), lung fibroblasts (lanes 3 and 
4), amnion cells (lanes 5 and 6), and mammary epithelial cells 
(lanes 7and 8) were incubated at 37°C for 4 h with (+) or with- 
out (-) 1 mIU of heparitinase. After incubation, the samples were 
made 2%  in SDS, subjected to electrophoresis in 4%  NuSieve 
agarose gels, and electrotransferred onto Z probe. The blots were 
stained with a mixture of 20/~g/mi of each of the four anti-ECM 
HSPG mAbs (4B1, 7H9, 9C9, and 3H8). The arrow indicates the 
position of  the sample wells. Similar results were also obtained with 
skin fibroblasts (not shown). 
Topological  Arrangement of  the Matrix HSPG 
The localization of the epitopes within pericellular matrix 
structures, either the matrix surrounding connective tissue 
cells or the basement membrane underlying epithelial cells, 
was  confirmed  and  specified  by  electron  microscopical 
studies. 
Immunogold  labeling  of 20-~m  skin  sections  with  the 
anti-ECM HSPG mAbs resulted in the scattered deposition 
of grains on irregular fibrillar material in the immediate vi- 
cinity of the dermal fibroblast cell surface (Fig. 6 a). A clear 
space always separated the fibroblast plasma membrane from 
the gold deposits (Fig. 6 b). Similarly, immunogold labeling 
of ultracryosections of umbilical cord revealed the deposi- 
tion of gold on plaque-like material in the immediate vicinity 
of the cells in the Wharton's jelly (Fig.  6 c). 
lmmunogold labeling of ultracryosections of human skin 
also confirmed the localization of the ECM HSPG epitopes 
in the basement membrane (Fig. 7).  Using a mixture of all 
four mAbs, the gold deposits were located in both the lamina 
tara and the lamina densa, but they were more abundant at 
the side of the lamina densa facing the underlying dermis 
(Fig. 7  c). The ECM HSPG epitopes were also present in 
small clusters of amorphous material and associated with 
fibrils in the interstitial areas just beneath the lamina densa. 
Omission of the detergent from the incubation mixtures did 
not markedly influence the distribution or abundance of the 
grain deposits (Fig. 7 d). When the sections were incubated 
with individual mAbs, a differential staining pattern was ob- 
served (Fig. 8). While the epitope recognized by mAb 4B1 
(Fig. 8, a and c) appeared to be more distributed throughout 
the  basement  membrane,  mAb  3H8  recognized a  deter- 
minant that was concentrated at the interstitial side of the 
basement membranes by the anti-ECM  HSPG mAbs was 
confirmed in several other tissues.  In trachea,  the epithe- 
lial-mesencbymal  interface and  the  basement  membrane 
surrounding blood vessels were demarcated (Fig. 4  b).  In 
liver, the mAbs delineated the sinusoids and the portal ves- 
sels but also stained the portal fibroblasts (Fig. 4 c). In kid- 
ney, the antigen was detected primarily at the boundary of 
the tubuli, in the glomerular capsule, and in capillaries (Fig. 
4 d). In placenta, reactive material was present at the basal 
surface of the tropboblast and around blood vessels (Fig. 4 
e). The matrix HSPG was detected in umbilical cord (Fig. 
4f), in association with endothelial cells and the surface of 
smooth muscle cells, and also around mesenchymal cells of 
the Wharton's jelly. This staining of the basement membranes 
in human skin (Fig. 5, a-c) and of the Wharton's jelly (Fig. 
5, d-f) could be completely inhibited when the sections were 
incubated with the anti-ECM HSPG mAbs in the presence 
of purified fibroblast matrix HSPG (Fig. 5, compare b with 
c and e with f). 
Figure 2. Peptide mapping  of the immunoreactive  HSPGs from col- 
tured epithelial and fibroblastic cells.  The heparitinase-digested 
scraped ECM of  amniotic fluid cells (lanes I and 2), mammary epi- 
thelial cells (lanes 3 and 4), and lung flbroblasts (lanes 5 and 6) 
were incubated with (+) or without (-) S. aureus V8 pmtease, sub- 
jected to SDS-PAGE, and electrotransferred onto Z probe. The blot 
was stained with the four anti-ECM HSPG mAbs as in Fig. 1. As- 
says with single antibody probes also detected similar peptides in 
different cells, mAb 4131 reacted only with 100-200-kD peptides, 
whereas mAbs 3H8 and 7H9 also stained bands of lower relative 
molecular mass. mAb 9C9, in contrast, produced only very weak 
signals on blots of the protease digests (not shown). 
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tured cells. Indirect immunoperoxidase  staining of a normal human 
lung fibroblast  cell culture (a) and an epithelial (HBL 100) cell cul- 
ture (b) using mAb 9C9 stains the flbfillar network between the 
cells. In contrast, staining of  a normal human fibroblast  cell culture 
with mAb F58-7F9, an antibody that reacts with a cell surface- 
associated HSPG, lightly stains the contours of the cells (c). Bars, 
100 ~m. 
lamina densa (Fig. 8, b and d). In contrast, staining of the 
human skin basement membrane cryosections with a poly- 
clonal antiserum directed against collagen type IV showed 
a  grain distribution throughout the whole thickness of the 
basement membrane (Fig. 7 b). Taken together, these results 
suggest that the core proteins penetrate both layers of the 
basement membrane but that a specific domain of the mole- 
cules is facing or might even be inserted in the underlying 
connective tissue. 
Relationship of the Matrix HSPG to the LDPG  from 
the EHS Tumor 
Because of this occurrence in basement membranes and be- 
cause a similar proteoglycan is expressed by epithelial cells, 
we investigated the cross-reactivity of the fibroblast matrix 
HSPG with antibodies raised against the LDPG of the base- 
ment membrane-producing EHS  tumor.  Western blots of 
human  fibroblast ECM  that  were  stained  with  the  anti- 
EHS LDPG antiserum showed heparitinase-sensitive proteins 
with similar relative molecular masses as those recognized 
by the anti-ECM HSPG mAb panel (Fig. 9 a). Both the an- 
tiserum and the panel stained the ,x,400-kD core protein and 
some smaller degradation products present in the sample. 
The anti-EHS LDPG antiserum also recognized two major 
core protein fragments that were detected by the mAb panel 
in protease V8 digests of  the matrix proteoglycans (Fig. 9 b). 
To exclude the possibility that the anti-EHS LDPG antise- 
rum and the anti-ECM HSPG mAbs would recognize two 
antigenically  different, but structurally similar proteoglycans 
of the fibroblast ECM, ~25I-labeled fibroblast matrix HSPG 
was  immunopurified using the mAbs  (see  Materials and 
Methods) and  tested  for binding to protein  A-Sepharose 
beads substituted with either rabbit anti-mouse IgG or with 
the rabbit anti-EHS LDPG antiserum. Nearly 84%  of the 
immunopurified fibroblast matrix HSPG was bound by the 
rabbit anti-EHS LDPG-protein A beads, whereas the con- 
trol rabbit anti-mouse IgG-protein A beads, as a test for pos- 
sible mAb-HSPG complexes, bound only 29%  of the  ~25I 
label.  Separate immunopurification experiments, in which 
the anti-ECM HSPG mAbs were used individually and con- 
secutively, established that all ECM HSPG epitopes were 
carded by a single type of R25I-fibroblast matrix proteogly- 
can (not shown). Moreover, the fibroblast matrix HSPG was 
able to completely block the labeling of the basement mem- 
branes of human tissues by the anti-EHS LDPG antiserum, 
suggesting that the HSPG from the fibroblast matrix con- 
tained  (at  least)  the  same  cross-reactive  epitopes  as  the 
HSPG  present  in  human basement membranes  (Fig.  10, 
compare b with c). Interestingly, at the ultrastructural level, 
the incubation of human skin sections with the anti-EHS 
LDPG antiserum yielded a  similar staining pattern as ob- 
tained  with  the  mAb  panel,  labeling  predominantly the 
stromal side of the lamina densa (Fig.  11 a). In mouse skin 
basement membranes,  in contrast,  this antiserum showed 
strong and uniform reactivity throughout the whole base- 
ment membrane (Fig.  11, compare a  with b). 
Finally, two amino acid sequences obtained from the anal- 
ysis of protease V8 fragments of the core protein of the hu- 
man fibroblast matrix HSPG showed a striking similarity to 
the amino acid sequence of the mouse EHS basement mem- 
brane LDPG that has been deduced from the analysis of cor- 
responding eDNA clones (Noonan et al.,  1988)  (Fig.  12). 
One  amino  acid  sequence  was  identical  (except  for  two 
unknowns) to a sequence of the EHS LDPG that shows ho- 
mology to N-CAM and to am-/~ glycoprotein (cDNA clone 
BPG7, amino acids 293-313).  The other sequence was ho- 
mologous (except for two mismatches-Gln vs. Arg and His 
Heremans et al. Pericellular Matrix Heparan Sulfate Proteoglycan  3203 Figure 4. Distribution of the matrix HSPG in human tissues. Staining of human skin sections (a) with mAb 9C9 reveals the presence of 
high concentrations of HSPG in the basement membranes of endothelia and epidermis. Staining of human trachea (b), liver (c), kidney 
(d), placenta (e), and umbilical cord (f) with mAb 9C9 displays the HSPG predominantly at the level of the basement membrane but 
also reveals stain around portal fibroblasts (c) and around cells from the Wharton's jelly (f). SM, smooth muscle; WH, Wharton's jelly. 
Bars,  1130 #m. 
Figure 5. Specificity  of the immunostaining of basement membranes and fibroblast pericellular  matrices. Indirect immunoperoxidase stain- 
ing of human skin (a, c, and e) and human umbilical cord (b, d, and f) sections that were pretreated without first antibody (a and b) or 
with a mixture of the four anti-ECM HSPG mAbs (c-f) either in the absence (c and d) or the presence (e and f) of competing HSPG 
isolated from the matrix of cultured human fibroblasts. The staining of the basement membranes of human epidermis (EP), smooth muscle 
cells (SM), and the matrix around cells of the Wharton's jelly (WH) was completely blocked by the fibroblast proteoglycan. Bars, 100 #m. 
The Journal of Cell Biology.  Volume 109, 1989  3204 Heremans et al. PericeUular Matrix Heparan Sulfate Proteoglycan  3205 Figure 6. Immunogold labeling of  the pericellular matrix of stromal 
cells with the anti-ECM  HSPG mAbs. In a and b, a cryosection 
of human skin is labeled with mAb 9C9. This reveals the HSPG 
in amorphous material in immediate proximity to a dermal fibro- 
blast (FB). No gold is seen on the cell membrane (M) itself or on 
the more distant collagen fibers (CF). In c, an ultrathin cryosection 
of umbilical cord is stained with a mixture of the mAbs, revealing 
the HSPG in plaque-like material in the vicinity of a stromal cell 
(SC) from the Wharton's jelly. The arrows point to areas where the 
cell boundaries are more distinct. Bars, 1 ~tm. 
vs. Gin- and two unknowns) to a segment of the EHS LDPG 
core protein in the cysteine-free regions separating cysteine- 
rich domains (eDNA clone BPG5, amino acids 439-459). 
These data indicate that the HSPG that accumulates in the 
pericellular matrix of fibroblasts shows extensive structural 
similarity  to  the  large  LDPG(s)  that  occurs in  basement 
membranes. 
Discussion 
Our  previous studies  on cultured human  lung  fibroblasts 
have provided evidence for several different forms of mem- 
brane-associated HSPGs (Lories et al.,  1987;  De Boeck et 
al.,  1987; Lories et al.,  1989) but for only a single matrix- 
associated HSPG (Heremans et al., 1988). This ECM com- 
ponent is a major proteoglycan of cultured fibroblasts, rep- 
resenting nearly 40%  of the [35S]HSPG in the monolayer 
(Lories et al.,  1986). The data reported here provide bio- 
chemical  and  morphological  indications  that  this  matrix 
HSPG is a ubiquitous component of epithelial and mesen- 
chymal cell-matrix interfaces: i.e., that it is identical to or 
related to the "basement membrane pmteoglycan(s)7 Im- 
munogold microscopy using mAbs suggests that this pericel- 
lular matrix HSPG might be vectorially inserted in basement 
membranes: i.e., that these proteoglycans may adopt a spe- 
cific orientation with respect to the cell-matrix interface. 
Epithelial and mesenchymal cells in culture seem to pro- 
duce this large matrix proteoglycan as shown by immuno- 
chemical and immunomicroscopical analysis using four mAbs 
specific for four different epitopes in the core protein of the 
fibroblast matrix HSPG (Figs. 1 and 3). The relative molecu- 
lar mass of the fibroblast core protein is estimated at ,~,4(D,000 
since it comigrated with the A  chain of laminin in  SDS- 
electrophoresis and was even somewhat more retarded than 
this  marker protein after complete reduction of its disul- 
fide bonds. This relative molecular mass estimate represents 
a  correction with respect to previously reported values of 
300,000:360,000 (Heremans et al., 1988) where this marker 
had not been included. The similarity of the ,~400-kD core 
proteins within the different cultured cell types could be con- 
firmed by V8 protease peptide mapping (Fig. 2). In this con- 
text, the similarity of the sizes of the smaller cross-reactive 
core proteins that were detected in the culture media of the 
different cell lines and that could be degradation products of 
the large 400-kD core proteins (Fig.  1 b) may also be the 
reflection of a similar core protein structure in the different 
cell lines. 
The above results are reminiscent of prior investigations 
on basement membrane proteoglycans in a variety of tissues, 
where core sizes of 350--400 kD  have been reported, al- 
though basement membrane HSPGs with smaller core pro- 
teins (ranging from 20 to 180 kD) have also been described 
(Edge and Spiro, 1987; Fujiwara et al., 1984; Hassell et al., 
1980; Kanwar et al., 1984; Parthasarathy and Spiro, 1984). 
In our study, all immunoreactive HSPG core proteins that 
were isolated from the matrices of the different cultures had 
an apparent relative molecular mass of'~t00,(O but we can- 
not rule out the possible occurrence of additional, non--cross- 
reactive HSPG in those matrices.  However, the fibroblast 
matrix core protein appears rather sensitive to proteolytic 
degradation. It was observed that additional immunoreactive 
bands may appear with time in stored matrix samples or oc- 
casionally be present in the original matrix extracts (see Fig. 
9 a). Similar core protein breakdown has been observed dur- 
ing investigations on the EHS LDPG, where the extent of 
degradation was found to vary with the isolation procedure 
used (Panlsson et al.,  1987). 
The Journal of Cell Biology,  Volume 109, 1989  3206 Figure 7. Immunogold labeling of basement membranes with a mixture of the anti-ECM HSPG mAbs. Ultrathin cryosections of human 
skin (a-d) were labeled with rabbit anti-human type IV collagen polyclonal antibodies (b) or with a mixture of the four anti-ECM HSPG 
mAbs (4B1, 3H8, 7H9, 9C9) in buffer with (c) or without (d) detergent. Control sections were labeled with Au-conjugated goat anti-rabbit 
(not shown) or Au-conjugated rabbit anti-mouse IgG (a) only. EP, epithelium; BM, basement membrane; ST, dermal stroma. Bars: (a-c, 
e, and f) 1 ~m; (d) 0.1 /~m. 
Like  several  of  the  basement  membrane  HSPGs,  the 
HSPG from the matrix of human  fibroblasts shows  clear 
cross-reactivity with an antiserum raised against the LDPG 
from the mouse EHS tumor. This was demonstrated by West- 
ern blotting (Fig.  8) and sequential immunoadsorption ex- 
periments which assured that the mAbs and polyclonai an- 
tiserum were recognizing the same and not just a  similar 
proteoglycan. Structural similarity was further documented 
by amino acid sequence analysis of two core protein frag- 
ments obtained from the digestion of the fibroblast matrix 
HSPG with V8 protease (Fig.  12). It is possible that the mi- 
nor mismatches that were observed only represent species 
differences. Consistently, the epitopes corresponding to the 
anti-ECM HSPG mAb panel were detected in the basement 
membranes of all human tissues examined (Fig. 4), while the 
staining of the basement membranes,  either by the mAbs 
(Fig.  5)  or by the anti-EHS  LDPG antiserum  (Fig.  10), 
could be completely inhibited by preincubation of the anti- 
bodies with matrix HSPG from fibroblasts. Taken together, 
these results strongly suggest that the HSPG from fibroblast 
matrices belongs to the family of the basement membrane 
HSPGs  and  extend prior  histochemical  identifications of 
anti-EHS LDPG antserum-cross-reacfive matrix fibers in 
cultured hamster fibroblasts (Singer et al.,  1987). 
In the above context it seems important to stress that the 
basement membrane proteoglycan is also accumulating on 
fibrillar matrix structures that surround fibroblasts in vivo. 
Both light microscopical (Fig. 5) and ultrastructural investi- 
Heremans et al. PericeUular  Matrix Heparan Sulfate Proteoglycan  3207 Figure 8. Immunogold labeling of basement membranes with single anti-ECM mAbs. Ultrathin sections of human skin labeled with mAb 
4B1 (a and c) or with mAb 3H8 (b and d) in buffer with detergent. EP, epithelium; BM, basement membrane; ST, dermal stroma. Bars, 1/~m. 
Figure 9. Antigenic similarity ofth  e human fibroblast matrix HSPG 
and murine basement membrane HSPG. (a) Suspensions of  scraped 
matrix of human lung fibroblasts were incubated with (+) or with- 
out (-) 1 mlU of heparitinase,  subjected to NuSieve agarose gel 
electrophoresis,  and electrotransferred onto Z probe. The Western 
blots were  reacted with  a mixture  of the four anti-ECM HSPG 
mAbs (lanes I and 2) or with the anti-EHS LDPG antiserum (lanes 
3  and  4).  (b)  Human lung  fibroblast  matrix was digested  with 
S. aureus V8 protease for varying lengths of  time, and Western blots 
of the resulting fragments were analyzed with the mixture of mAbs 
(lanes 1-3) or with the anti-EHS LDPG antiserum  (lanes 4-6). 
gations (Fig.  6),  showing the ECM HSPG epitopes in the 
connective  tissue  immediately  surrounding  dermal  fibro- 
blasts and around mesenchymal cells in the Wharton's jelly, 
locate the matrix HSPG at stromal cell-matrix interfaces. 
These  data  seem  in  agreement  with  observations  in  the 
mouse cornea, where plaques of basement membrane-like 
material that react with anti-EHS LDGP antisera occur in 
the stroma, in contact with fibroblasts and in association with 
large collagen fibers (Schittny et al.,  1988). The expression 
of basement membrane proteoglycans by fibroblasts is thus 
not merely an artifact of tissue culture. 
The basement membranes, however, are the pericellular 
matrix structures where this type of proteoglycan seems to 
abound (Fig. 4). Interestingly, in human skin basement mem- 
branes the epitopes that were recognized by either the anti- 
ECM HSPG mAb mixture (Fig. 7) or by the anti-mouse EHS 
LDPG antiserum (Fig. 11 a) seemed located in both the lam- 
ina rara and lamina densa,  but the gold grains were more 
concentrated at the basal side of the basement membrane, 
where they also occurred in association with underlying fi- 
brils in the dermis. This nonhomogeneous staining of the hu- 
man basement membranes seemed specific for the  HSPG 
probes since, for example, type IV collagen could be detected 
The Journal of Cell Biology, Volume  109, 1989  3208 Figure 11. Immunogold labeling of basement membranes with the 
anti-EHS LDPG antiserum.  Human (a) and mouse (b) skin ultra- 
cryosections labeled with anti-EHS LDPG rabbit antiserum.  The 
control sections using goat anti-rabbit IgG only were negative (not 
shown).  EP,  epithelium;  BM,  basement  membrane; S~,  dermal 
stroma.  Bars,  1 ttm. 
throughout the basement membranes. This impression was 
strengthened by stainings that used single mAb probes, where 
the 3H8 epitope appeared confined to the stromal side of the 
basement membrane (Fig.  8).  In mouse skin, however, the 
anti-EHS  LDPG antiserum yielded a  strong and  uniform 
reaction all across the basement membrane, showing no par- 
ticular concentration of epitopes at the lamina densa-inter- 
stitial matrix interface (Fig.  11  b). 
Figure 10. Cross-reactivity of the anti-EHS LDPG antiserum with 
fibroblast matrix  HSPG.  Immunostaining  with peroxidase-conju- 
gated swine anti-rabbit antibodies of  human skin sections that were 
pretreated either without first antibody (a) or with anti-EHS LDPG 
antiserum in the absence (b) and in the presence (c) of competing 
HSPG isolated from the matrix of  cultured human fibroblasts. Bars, 
100 #m. 
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b  G  Q  T  L  D  L  x  C  V  V  x  G  Q  A  H  A  Q V  T  W  ECM  HSPG (major) 
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Figure  /2.  Sequence similarity of the  human  fibroblast matrix 
HSPG and the murine EHS LDPG. HSPG isolated from the ECM 
of cultured human lung fibroblasts was digested with S. aureus V8 
protease. The digest was ffactionated by SDS-PAGE and electro- 
blotted on an Immobilon membrane. A prominent 13.5-kD band 
was excised for sequencing. One major and one minor signal, re- 
vealing the comigration of  two peptides, were obtained. The signals 
could be read and distinguished unambiguously for 20 cycles, ex- 
cept at two locations (indicated by X in the sequences). Residues 
293-313 of the amino acid sequence deduced from cDNA clone 
BPG7 (a) are aligned with the amino acid sequence from the major 
signal (b), while the sequence derived from the minor signal (c) is 
aligned with residues 439-459 of  the amino acid sequence deduced 
from cDNA clone BPG5 (d). Both cDNAs encode different por- 
tions of  the EHS LDPG (Noonan et al., 1988). The arrows indicate 
potential V8 protease cleavage sites in the EHS LDPG. 
One possible explanation for the findings in human and 
mouse tissues  could be a  vectorial insertion (preferential 
orientation) of the proteoglycan in the basement membrane, 
whereby a  specific part (presumably one end) of the core 
protein would be in contact with the underlying stroma and 
the rest of the molecule would penetrate both laminae of the 
basement membrane. The estimated length (80 nm) of the 
basement  membrane  HSPG  core  protein  (Laurie  et  al., 
1988; Paulsson et al.,  1987) seems compatible with such a 
proposal and could account for a scatter of grains over the 
whole thickness of the basement membrane. In that case, the 
homogeneous staining of the mouse basement membrane by 
the anti-EHS LDPG antiserum may be attributable to the 
recognition of a broad range of epitopes covering the whole 
length of the core, whereas the human cross-reacting epi- 
topes and the epitopes that are recognized by the mAbs may 
be restricted to a particular domain of the core, explaining 
the nonhomogeneous staining of the human basement mem- 
branes. This interpretation seems corroborated by the obser- 
vation that  the  anti-EHS  LDPG antiserum  stains  only a 
limited number of the fragments generated by digesting the 
human core protein with protease V8 (Fig. 9 b). Alternatively, 
the difference in staining could be due to a species difference 
in the organization and masking of the HSPG within the 
different layers of the skin basement membranes. The result 
with the anti-EHS LDPG serum in the mouse tissue is in 
agreement with previous ultrastructural studies that have de- 
tected the HSPG all across the basement membrane (Grant 
and  Leblond,  1988;  Laurie et al.,  1982;  Schittny et al., 
1988). However, an antiserum raised against rat glomerular 
basement membrane HSPG has been found to stain only the 
lamina rata (Stow et al.,  1985). On the assumption that the 
different antisera were recognizing different parts of equiva- 
lent molecules, these findings could also be interpreted in 
terms  of a  vectorial insertion of the  proteoglycan in  the 
matrix. 
To clarify this  issue  on the organization of the  matrix 
HSPG, additional experiments are needed, including the ex- 
tension  of the  mAb  panel,  the  mapping  of the  mAbs  to 
specific domains of the proteoglycan core proteins, and the 
enhancement of the sensitivity of the immunolabeling tech- 
nique on ultracryosections. This need is emphasized by the 
available sequence information which predicts the occur- 
rence of structural repeats within the core (Noonan et al., 
1988), whereby certain probes may not be informative. So 
far, the concentration of these HSPGs in plaque-like matrix 
structures that are bound to collagen fibers in the immediate 
vicinity of the fibroblast cell surface and at the side of the 
basement membranes where this membrane abuts the con- 
nective tissue implies that these ubiquitous proteoglycans 
may have a specific function in the anchorage of the pericel- 
lular matrices to the interstitial matrix. 
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